Aimei Health Technology Co Ltd [NASDAQ: AFJK] jumped around 80.29 points on Tuesday, while shares priced at $88.5 at the close of the session, up 977.95%.
Aimei Health Technology Co Ltd stock is now 768.50% up from its year-to-date (YTD) trading value. AFJK Stock saw the intraday high of $98.15 and lowest of $9.3765 per share. The company’s 52-week high price is 41.80, which means current price is +1,211.11% above from all time high which was touched on 12/09/25.
Compared to the average trading volume of 22.92K shares, AFJK reached a trading volume of 6504141 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Aimei Health Technology Co Ltd [AFJK]?
The Price to Book ratio for the last quarter was 12.90, with the Price to Cash per share for the same quarter was set at 0.00.
How has AFJK stock performed recently?
Aimei Health Technology Co Ltd [AFJK] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 883.33. With this latest performance, AFJK shares gained by 608.00% in over the last four-week period, additionally plugging by 733.33% over the last 6 months – not to mention a rise of 727.10% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AFJK stock in for the last two-week period is set at 93.64, with the RSI for the last a single of trading hit 11.35, and the three-weeks RSI is set at 6.07 for Aimei Health Technology Co Ltd [AFJK]. The present Moving Average for the last 50 days of trading for this stock 12.79, while it was recorded at 24.34 for the last single week of trading, and 11.23 for the last 200 days.
Aimei Health Technology Co Ltd (AFJK) Capital Structure & Debt Analysis
According to recent financial data for Aimei Health Technology Co Ltd. ( AFJK), the Return on Equity (ROE) stands at 2.47%, suggesting modest shareholder returns. The Return on Assets (ROA) is 2.38%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Aimei Health Technology Co Ltd’s Return on Invested Capital (ROIC) is 3.35%, showcasing its effectiveness in deploying capital for earnings.
Aimei Health Technology Co Ltd (AFJK) Efficiency & Liquidity Metrics
Based on Aimei Health Technology Co Ltd’s (AFJK) latest financial statements, the Debt-to-Equity Ratio is 0.04%, indicating its reliance on debt financing relative to shareholder equity.
Aimei Health Technology Co Ltd (AFJK) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Aimei Health Technology Co Ltd. (AFJK) effectively leverages its workforce, generating an average of $705000.0 per employee. The company’s liquidity position is robust, with a Current Ratio of 0.01% and a Quick Ratio of 0.01%, indicating strong ability to cover short-term liabilities.
Insider trade positions for Aimei Health Technology Co Ltd [AFJK]
There are presently around $60.20%, or 90.66%% of AFJK stock, in the hands of institutional investors. The top three institutional holders of AFJK stocks are: KARPUS MANAGEMENT, INC. with ownership of 1.1 million shares, which is approximately 12.2253%. FIRST TRUST CAPITAL MANAGEMENT L.P., holding 0.68 million shares of the stock with an approximate value of $$7.04 million in AFJK stocks shares; and FIRST TRUST CAPITAL MANAGEMENT L.P., currently with $$6.09 million in AFJK stock with ownership which is approximately 6.5231%.
